Califf: PDUFA Funds Will Run Dry In November, Congress Needs To Act

By Beth Wang / August 1, 2022 at 5:02 PM
FDA’s prescription drug user fee program will run out of funding about five weeks into fiscal 2023 -- early November -- if Congress does not pass legislation to reauthorize the agency’s drug, medical device and biosimilars user fee programs before they expire at the end of September, FDA Commissioner Robert Califf wrote in a memo to FDA staff Friday (July 29). Congress needs to act quickly to reauthorize the programs so the agency can avoid sending layoff notices, he added...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.